The testing of injecting RNA into Alzheimer's patients to reduce the levels of tau proteins is a possible new treatment for the more than 5.1 million people living with Alzheimer's. The treatment has shown some limitation in the testing done on chimps, more testing will be done on primates to discern the safety and efficacy on humans.